1. Introduction {#s0010}
===============

The phylum Apicomplexa comprises a large group of complex eukaryotic organisms known to be obligate parasites of vertebrates and invertebrates. These organisms share a common characteristic of having an apical complex which contains secretory organelles considered to be involved in invasion and/or establishment of the parasite in the mammalian or invertebrate host ([@bib0125]). The phylum is divided into four principal groups; the Coccidia, Gregarinasina (gregarines), Haemospororida (haemosporidians) and the Piroplasmorida (piroplasmids) ([@bib0020]). The Piroplasmorida comprises two main genera (*Babesia* and *Theileria*) responsible for the economic important diseases of domestic and wild animals. New species of the piroplasmids are still being discovered and their full biology is not completely documented yet. Many of this order\'s parasites were formerly classified based on morphology, host cells in which schizogony occurs, the observation of piroplasms in the red blood cells associated with disease manifestation and host-vector specificity ([@bib0085; @bib0995]). The genus *Theileria* is distinguished by infection of leukocytes by sporozoites, maturation of schizonts into merozoites and subsequent infection of red blood cells to form piroplasms ([@bib0995]).

A generalised lifecycle for the *Theileria* genus include secretion of infective sporozoites during tick feeding into the feeding site ([Fig. 1](#f0015){ref-type="fig"}). Sporozoites then infect leukocytes and multiply by merogony, after which merozoites are released, which invade red blood cells thereby establishing the piroplasm stage. During a next feeding cycle, larval or nymphal vector ticks ingest piroplasms and the released parasites undergo syngamy in the tick gut, forming a zygote, the only diploid stage. The zygote divides into motile kinetes that infect the tick gut epithelial cells and migrate to the haemolymph and subsequently infect the salivary glands. After moulting and commencement of feeding by the tick, sporogony results in the multiplication of sporozoites in the salivary gland acini before injection into the feeding site by nymphs or adult ticks ([@bib0630]).

The *Theileria* species infect a wide range of both domestic and wild animals and are transmitted by ixodid ticks of the genera *Amblyomma, Haemaphysalis, Hyalomma* and *Rhipicephalus*. Most of these ticks are renowned for the large economic losses they cause to the agricultural industry due to disease outbreaks, mortalities, damage to hides and poor production in domestic animals ([@bib0125]). The expansion of wildlife husbandry and conservation has also made *Theileria* of wildlife important subjects of study. The *Theileria* can be grouped into schizont "transforming" and "non-transforming" species ([@bib0910]). Transforming parasites all group in the *T. taurotragi* clade ([Fig. 2](#f0020){ref-type="fig"}) ([@bib0910]), and uncontrolled proliferation of schizonts results in the pathologies associated with Corridor disease (*Theileria parva*), East Coast fever (*T. parva*), Tropical theileriosis (*T. annulata*) in cattle and malignant theileriosis (*T. lestoquardi*) in goats and sheep ([@bib0125; @bib0630]). However, *T. taurotragi, T.* sp. (buffalo) and *T.* sp. (bougasvlei) do not cause schizont associated pathology ([@bib1050; @bib0125; @bib0785]). *Theileria* sp. (sable), that group within the antelope *Theileria* ([Fig. 2](#f0020){ref-type="fig"}), causes lymphoid hyperplasia typically associated with the transforming *Theileria* ([@bib0670]). This and the ability to culture schizonts ([@bib1095]) indicate that not all transforming parasites share a monophyletic origin ([@bib0910]), which suggests that transformation of schizonts may occur more widely than expected. The non-transforming *Theileria* are regarded as being benign but still able to cause disease as a result of anaemia induced by the piroplasm stage ([@bib0910]). The last decade has seen an increase in the discovery of new *Theileria* species and genotypes and the realisation that even domestic animals may harbour an extensive array of mixed infections ([@bib0245; @bib0605; @bib0910]). This is compounded by mixed *Theileria* infections in both mammalian hosts and tick vectors where wildlife and livestock share the same habitat and common tick species ([@bib0540; @bib0460]). The means to discriminate benign and virulent forms as well as species responsible for disease outbreaks is becoming more important, both for diagnostic and epidemiological purposes.

2. Diagnostics {#s0015}
==============

Diagnostic methods are used alone or in combination with other criteria to accurately diagnose disease. The use of assays as diagnostic tools needs to fulfil some pre-requisites albeit for human or veterinary use ([@bib0765; @bib0155; @bib0750]). As such the basic performance characteristics of a test need to be determined against a reference standard. This would generate data on reproducibility, sensitivity and specificity of the particular assay, parasite prevalence, genetic variation and/or methodology used: type of antigen or antibody, automated or manual procedures, all contributing to the variables influencing any given assay\'s performance.

2.1. Microscopy {#s0020}
---------------

Historically most *Theileria* species were first described based on light microscopy examination after Koch\'s discovery of *T. parva* ([@bib0510]). It was usually performed on Giemsa stained blood smears, however, the limitation of light microscopy as a diagnostic tool was that the detection of carrier animals regularly went unnoticed and the discrimination between piroplasms of other *Theileria* species were difficult as they are morphologically very similar ([@bib0270; @bib0945; @bib0530; @bib0535; @bib0990]). Even so, discovery of novel species may still utilise morphology as part of their formal description ([@bib0670; @bib0210; @bib0705; @bib0740]), and remains a fast method to derive at an initial differential diagnosis of potential theileriosis in clinical cases ([@bib0670; @bib0420]). In regard to routine diagnostics, microscopy is several orders of magnitude less sensitive than molecular methods ([@bib0235]), and generally unable to accurately detect all carrier-state animals ([@bib0535; @bib1090]).

2.2. Xenodiagnosis {#s0025}
------------------

Xenodiagnosis (tick pickup and transmission linked with clinical disease) as demanded by Koch\'s postulate was used to confirm disease-causing species and tick vectors ([@bib0270; @bib0945; @bib1050; @bib0915]). Direct injection of infected blood may also distinguish species amenable to proliferation in the piroplasm stage ([@bib0950]). Xenodiagnosis remains a useful tool in basic parasite research and epidemiological investigations and may be the only means to confirm tick vector designation and clinical pathology of specific *Theileria* strains or as first step in parasite isolation ([@bib0660; @bib0925; @bib0625]). It is, however, not suitable for high-throughput or routine analysis and remains in the domain of specialised research groups.

2.3. Serological assays {#s0030}
-----------------------

Serological diagnosis by complement fixation ([@bib0565]) was followed by the more advanced indirect fluorescent antibody test (IFAT) ([@bib0865; @bib0145; @bib0150]). Antigen may be prepared from schizont or piroplasm antigen, derived from infected animals or cell culture. Cell culture of *Theileria* parasites may be useful in diagnosis of carrier state animals ([@bib1090]), to identify transforming parasites ([@bib1095; @bib1100]), as means to generate IFAT antigen ([@bib0150]), and distinguish different species and investigate distinct parasite populations using monoclonal antibodies ([@bib0225; @bib0130; @bib0030; @bib1100]). The IFAT remains the gold standard assay recommended by the OIE for most economically important parasites ([@bib0700]). The IFAT has several drawbacks, namely, subjective operator-dependent interpretation of results, low throughput and difficulty in standardisation ([@bib0465]). However, the biggest problem with the IFAT is the significant cross-reactivity observed between closely related species. Cross-reactivity between *T. parva* and *T. taurotragi* antigen and anti-sera has been observed ([@bib0250; @bib0440]). Similar observation has been made in regard to *T. parva* and *T.* sp. (buffalo) ([@bib0225; @bib0785]). An IFAT assay for *T. lestoquardi* showed significant cross-reactivity with *T. annulata* and *T. parva* anti-sera and *vice versa* ([@bib0550]). Detection by IFAT may therefore be a poor measure to assign parasites to species ([@bib0990; @bib1005; @bib0920]), especially when closely related, such as the genotypes found in the *T. buffeli, T. mutans* and *T. velifera* clades ([Fig. 2](#f0020){ref-type="fig"}). Even so, IFAT may still be useful in epidemiological studies ([@bib0960; @bib0625]), or where certain species are absent in specific carrier hosts such as the case for *T. taurotragi* and African buffalo (*T. parva* carrier) ([@bib0605]), or *T. annulata* in small ruminants (*T. lestoquardi* carrier) ([@bib0550]).

The IFAT utilises whole-body antigen, but the realisation that a select number of antigens are responsible for the dominant immune response against most *Theileria* parasites has stimulated interest in enzyme-linked immunosorbent assays (ELISA) ([@bib0465]). These single molecule assays have the promise of more species specific antigens amenable to high throughput analysis. The polymorphic immunodominant molecule (PIM) of *Theileria parva* and the p32 antigen of *T. mutans* were used to develop ELISAs ([@bib0470; @bib0465; @bib0645]). Both were commercially marketed and shown to be more sensitive than the IFAT, but the tests were discontinued due to specificity issues ([@bib0700]). However, both are still being used in research ([@bib0930; @bib0090; @bib0490]). The EMA-1 antigen for *T. equi* and a monoclonal antibody against this antigen were used to develop a competitive inhibition ELISA ([@bib0505]) that is available as a commercial kit and considered as replacement for the IFAT ([@bib0700]). The EMA-2 antigen for *T. equi* was also investigated in an indirect ELISA and as rapid immune-chromatographic test ([@bib0405; @bib0410]). Other ELISAs developed include the *T. annulata* merozoite surface 1 antigen (Tams1) and the *T. annulata* macroschizont stage protein (TaSP) ([@bib0355; @bib0880; @bib0795]), a heat-shock 70 antigen for *T.* sp. (China) ([@bib0635]) and *T. uilenbergi* immunodominant protein (TuIP) ([@bib0595]). TaSP was also used to develop a rapid lateral flow device assay for *T. annulata* that compares well with other serodiagnostic assays ([@bib0010]). One of the biggest advantages of ELISA is in its use as a high throughput, cheap and fast method to screen and diagnose large numbers of samples. In this regard, serodiagnosis remains the workhorse for laboratories where molecular infrastructure does not exist.

2.4. Molecular assays {#s0035}
---------------------

The molecular revolution saw an explosion of diagnostic assays ([@bib0235]), that is target specific genes and species ([Table 1](#t0010){ref-type="table"}). This included conventional PCR followed by agarose gel electrophoretic analysis ([@bib0120; @bib0770]), PCR-RFLP methods ([@bib0120; @bib0305; @bib0390; @bib1070]), nested-PCR ([@bib0690]), PCR followed by dot blotting, capillary blotting or slot-blotting and hybridisation using radio-isotope labelled probes ([@bib0120; @bib0040; @bib0215; @bib0915]). The latter was improved by the non-radio-active reverse line blot method that used chemiluminescence ([@bib0350; @bib0875]), with recent variation on this technique using a DNA bead-based suspension array ([@bib0800; @bib0810]). This was followed by probe based real-time PCR methods ([@bib0430; @bib0495; @bib0895; @bib0105; @bib0775; @bib0785; @bib0805]), SYBR green real-time PCR assays ([@bib0780]), loop-mediated isothermal amplification (LAMP) assays ([@bib0030; @bib0035; @bib0590; @bib0575; @bib0580; @bib0815; @bib0820; @bib0955; @bib1015; @bib1025]), pan-FRET based assays ([@bib0195; @bib0755; @bib1035]) and high-resolution melt analysis ([@bib0835]). In all cases, detection by molecular methods allow for direct confirmation of the presence of parasite genomic material, with the inference that live parasites are present in the animal at the moment of sampling. Developments from conventional to nested to real-time PCR has allowed improvement in sensitivity, quantification and speed of detection, while methods such as reverse line blot, bead arrays, pan-FRET assays and high-resolution melt analysis hold the promise of detection of multiple species or genotypes at the same time. Real-time melting profile based assays also hold the advantage that variation in probe regions may be detected by differences in melting profiles that may be related to genotypic or species differences. Whereas many of these assays require specialised equipment, LAMP assays hold the advantage of functioning at iso-thermal conditions, with possible application under field conditions.

3. Specificity of molecular assays and the species concept {#s0040}
==========================================================

Most molecular assays depend on primers and/or probes that target small regions of genes with the implicit assumption that these regions are conserved through all members of a species or genus. In the case of protein genes, the degenerate nature of the genetic code makes the design of specific primers or probes quite difficult, as exemplified by their reduced sensitivity compared to more conserved ribosomal genes ([@bib0770; @bib0780]). Protein genes on the other hand may provide much greater specificity due to more distant orthologous relationships ([@bib0690; @bib0770]). The challenge in the development of specific assays therefore lies in the identification of these unique regions within genes or a genome, working with often limited information regarding the diversity of a gene or the availability of total genome information. For example, the reverse line blot (RLB) was developed well before extensive genomic information was available for the *Theileria* genus or estimates regarding 18S rRNA diversity in domestic animals and wildlife ([@bib0350]). The RLB primers for *Theileria* and *Babesia* target the 18S rRNA regions that flank the V4 hyper-variable region and to date have been found to be conserved in all members of these genera ([@bib0350]). The probes used in the reverse line blot were assumed to be species-specific and to be able to detect all members of a species, based on the assumption that the 18S hyper-variable region is conserved within species. It is therefore also useful to detect new species in the case where only a *Theileria* catch-all probe is detected ([@bib0705; @bib0200; @bib0205]). More recently, some of these assumptions have been challenged.

Diagnostic screening of buffalo and cattle samples using the hybridisation real-time PCR for *T. parva* ([@bib0895]) detected samples with aberrant melting curves that suggested variation in the probe region of this assay that occurs within the 18S rRNA V4 hyper-variable region ([@bib0605]). Sequencing of these samples indicated single nucleotide polymorphisms, suggesting that variation in the V4 hyper-variable region may occur in individuals within the *T. parva* population ([@bib0605]). In geographically isolated populations these polymorphisms may become fixed, leading to cases where species identity may be questioned. It was as such proposed that organisms with 1--2 single nucleotide polymorphisms within the V4 18S rRNA hyper-variable region be considered the same species ([@bib0605]). Conversely, the interesting phenomenon exists, that certain genotypes within the *Theileria* genus show extensive genotypic variation within the 18S rRNA hyper-variable region, but due to the fact that these groups within the same clade during phylogenetic analysis are considered to be members of the same species. As such, 12 main clades for *Theileria* can be distinguished ([Fig. 2](#f0020){ref-type="fig"}), comprising at least 91 unique genotypes which may or may not be unique species as will be discussed later. The main clades found include the *T. buffeli, T. equi, T. mutans, T. taurotragi, T. velifera* clades, three clades for antelope *Theileria*, a clade for marsupial *Theileria* and for *Theileria annae*.

The *T. taurotragi* clade comprises multiple well-recognised species, even though their inter-species genetic distances are very similar to other clades ([@bib0605]). *Theileria taurotragi* has been found in antelope (bushbuck, eland) and cattle and occurs from East to Southern Africa ([@bib0615; @bib1050; @bib0250; @bib0725]); *T. annulata* infects cattle and causes tropical theileriosis, while *T. lestoquardi* infects small ruminants such as sheep and goats and causes malignant theileriosis ([@bib0555]); *T. parva* infects cattle and African buffalo ([@bib0685]); *T.* sp. (buffalo) infects African buffalo and has been detected in cattle ([@bib0040; @bib1100; @bib0605; @bib0770; @bib0325]); *T.* sp. (bougasvlei) infects African buffalo ([@bib1100; @bib0605; @bib0770; @bib0785]). *Theileria annulata* and *T. lestoquardi* differ by 2 base pairs in the hyper-variable region, while differences in this region between *T. parva, T.* sp. (buffalo) and *T.* sp. (bougasvlei) range from 4 to 6 base pairs ([@bib0605]). Even so, analyses using the nuclear S5 and mitochondrial COI genes distinguish these species quite well, while *T.* sp. (buffalo) and *T.* sp. (bougasvlei) also show disparate geographic distributions ([@bib0605; @bib0785]). All members of this clade can transform lymphocytes (assumed for *T.* sp. (bougasvlei)), but this phenomenon is not associated with pathology for all members ([@bib0610; @bib0910]).

*Theileria annae* is a parasite of dogs and other canines and is related to *Babesia microti* ([@bib1075; @bib0170; @bib0655]). It has been assigned to the genus *Theileria* based on the contention that the small canine Babesias are more closely related to *Theileria* than *Babesia* ([@bib1075]). However, molecular analyses of the 18S rRNA gene indicate a close relationship to the *Babesia* ([@bib0620; @bib0910]). Other Theilerias found incidentally in dogs include *T. annulata* and *T. equi* ([@bib0240; @bib0230; @bib0095]). However, a genotype identical to *T.* sp. (sable) has been found extensively in dogs surveyed in KwaZulu-Natal, South Africa ([@bib0670; @bib0620]). *Theileria* sp. (sable) groups within the clade of Antelope Theilerias have been found in an extensive range of other antelope as well ([@bib0670]). Since most of these identifications were done by RLB analysis these hosts remain to be confirmed by sequencing. The antelope clade is extensive and comprised of various genotypes found in different antelope species. In many cases, multiple genotypes have been found in single antelope species and are not distinguished by their genotype designation, even though their phylogenetic position would suggest that these may be unique species. This includes genotypes for *T.* sp. OT3 ([@bib0650; @bib0970]), *T. capreoli* ([@bib0295; @bib1030]), *T. cervi* ([@bib0175; @bib0180]), giraffe *Theileria* ([@bib0705; @bib0320]), waterbuck *Theileria* ([@bib0325]), white-tailed deer *Theileria*, water deer *Theileria* ([@bib0370]). Many of these genotypes have been identified in multiple antelope species, making designation according to host specificity difficult. One genotype from this clade has been identified in cheetah and shows a close relationship to a genotype found in giraffes ([@bib0315]).

The *Theileria* found in marsupials all cluster together and comprise 7 unique genotypes. *Theileria fuliginosa* is found in the western grey kangaroo (*Macropus fuliginosus*), *T. penicillata* in the woylie (*Bettongia penicillata ogilbyi*), *T. gilberti* in Gilbert\'s potoroo (*Potorous gilbertii*), *T.* sp. long-nosed potoroo in the long-nosed potoroo (*Potorous tridactylus*) and *T.* sp. K1 in the boodie (*Bettongia lesueur*) ([@bib0210; @bib0545; @bib0740]). Two distinct genotypes for *T. brachyuri* have been found in the quokka (*Setonix brachyurus*) ([@bib0210]), suggesting that at least one is a different species. At least three other marsupial *Theileria* exist for which no molecular data are available; they include *T. tachyglossi* in the echidna, *T. peramelis* in the southern brown bandicoot (*Isoodon obesulus*), and *T. ornithorhynchi* in the platypus (*Ornithorhynchus anatinus*) ([@bib0545; @bib0740]). The monophyletic relationship within this clade would suggest a single introduction into Australia, with subsequent host adaptations and speciation.

The *T. buffeli* clade possesses the most extensive number of genotypes (13) and occurs in all the major continents of the world, where they infect cattle, African buffalo, water buffalo and Yak ([@bib0195; @bib0910]). A number of different species names have historically been assigned to members of this clade including *T. buffeli, T. orientalis* and *T. sergenti*, but have been proposed to represent a single species designated as *T. buffeli* ([@bib0920; @bib0360; @bib0365]). This builds on a similar proposal by [@bib0990]) and [@bib1005] that used morphological and serological cross-reactivity to assign all members to *T. orientalis*. Both *T. buffeli* and *T. orientalis* continue to be used in literature depending on the historical background of different scientific groups ([@bib0205; @bib0910]). Another "species" that belongs to this group is *T. sinensis* ([@bib0065]). The genotypes from this clade were postulated to be in the process of speciation that has not been completed yet ([@bib0870]), while others considered members to be distinct species ([@bib0480; @bib0285]). Most members of this group are considered to be benign, but a recent outbreak of a virulent genotype (Ikeda type) in Australia readdressed the possibility of unique species in this group ([@bib0420; @bib0450]). More recently, related genotypes (*T. buffeli* C, *T. sinensis*-like) were found in African buffalo but not in cattle from the same geographic regions in southern Africa ([@bib0605; @bib0205]). All these genotypes are generally considered to be genotypic variants of *T. buffeli* ([@bib0185; @bib0360; @bib0365; @bib0205]), even though host specificity, clinical presentation and specific geographic distributions are different. The use of other genes such as the major piroplasm surface protein (MPSP) also generally groups different genotypes into separate clades that correspond with those obtained using the 18S gene ([@bib0450; @bib0910]). Serological and molecular assays that can distinguish different genotypes have been developed ([@bib0480; @bib0485; @bib0570; @bib0580; @bib0755]). It thus seem surprising that this clade does not have well recognised species, which complicates development of specific diagnostic assays and possible interpretation of diagnostic results. The relative caution in molecular species designation within this clade that occurred more than 14 years ago ([@bib0185; @bib0360]) has also permeated to other *Theileria* clades such as *T. mutans, T. velifera, T. equi*, the *Theileria* antelope clade and members of the *T. taurotragi* clade (discussed in their respective sections), irrespective of the fact that no recombination experiments have yet been attempted between different genotypes, that may warrant the conclusion of a single *Theileria* species per clade.

The *T. mutans* clade is comprised of five recognised genotypes, namely *T. mutans* that infects cattle and buffalo, *T. mutans* MSD that infects cattle and buffalo, *T. mutans*-like 1, *T. mutans*-like 2 and *T. mutans*-like 3 that has thus far been found only in African buffalo ([@bib0185; @bib0605; @bib0200]). Of interest is that the *T. mutans*-like 1--3 genotypes were not detected by the *T. mutans* RLB probe, but is still considered to be genotypic variants of *T. mutans* ([@bib0200]), even though they differ by 7--13 nucleotide as well as a gapped position ([@bib0605]). However, to date *T. mutans*-like 1--3 have only been observed in African buffalo and occur at significantly higher prevalence and parasitaemia compared to *T. mutans* and *T. mutans* MSD, which occur extensively in cattle (B.J. Mans, personal observation). Host specificity would therefore suggest that at least two species exist in this clade.

The *T. velifera* clade is comprised of four genotypes, *T. velifera, T. velifera A, T. velifera B* and *T.* sp. RR-2012, an as yet undescribed genotype from Indian bovines. *T. velifera* and *T. velifera A* have been found in cattle and buffalo, while *T. velifera B* has only been found in buffalo ([@bib0605; @bib0200]). Significant similarity exists between the RLB probe for *T.* sp. (sable) and *T. velifera*, so that reports of the extensive occurrence of the former in cattle and African buffalo ([@bib0670; @bib1065]) could be traced back to the presence of *T. velifera* ([@bib0605]). This again underscores the pitfalls of the RLB approach, when used for screening of novel vertebrate species or animals from new geographic regions, for which the assay has not been validated.

The *T. equi* clade shows similar genetic diversity as the *T. buffeli* clade (twelve genotypes) and is also considered to be representative of a single species ([@bib0495; @bib0100; @bib0830]). This is supported by extensive cross-reactivity on IFAT ([@bib0100]). Some genotypes have thus far been confined to equids other than horses, such as donkeys and zebra, but have also been found in waterbuck ([@bib0110; @bib0325]). Whether these will infect horses remains to be determined, but the wide distribution observed for most genotypes suggests that none are host specific ([Fig. 2](#f0020){ref-type="fig"}). Multiple genotypes also generally occur in similar geographic localities which make the assessment of strain virulence difficult, with the general assumption that all strains present similar virulence and pathologies. A recently developed real-time PCR assay selected a region within the 18S ribosomal RNA gene, for which both primers and probes are conserved in the *Theileria* ([@bib0495; @bib0105]). It will therefore detect all genotypes from *T. equi* when used to screen equids but will not be useful for screening other animals suspected to harbour *T. equi* such as waterbuck ([@bib0325]). From an equid epidemiological control perspective this may be ideal if the clade is treated as a single species or virulent group. However, from a phylogeographic perspective where evolution of unique genotypes is considered, large-scale surveys that rely on diagnostic assays will be hampered.

Two genotypes that do not fit into any major clade include *T. bicornis* found in black, Indian and white rhinoceros ([@bib0665; @bib0715]). The other was found in domestic cats in a Brazilian zoo and may be an incidental infection transmitted from another felid carrier ([@bib0060]).

The origin of the genotypic diversity observed should be considered. To date genomes for *T. annulata, T. equi, T. parva* and *T. orientalis* have been sequenced and all indicate the presence of two 18S ribosomal RNA genes ([@bib0300; @bib0730; @bib0385; @bib0455]). In all cases these genes are highly conserved, most probably due to concerted evolution ([@bib0275]), with the implication that genotypic diversity observed within the 18S gene for the *Theileria* is not due to multiple gene copies within their genomes ([@bib0605]). Genotypic diversity observed in the 18S genes will therefore be due to conventional divergent evolution, linked with mutation and insertion--deletion events.

The genotypic diversity observed within the *Theileria* has interesting implications from a diagnostic perspective. On the one hand, some species such as *T. annulata, T. lestoquardi, T. parva, T.* sp. (buffalo) and *T.* sp. (bougasvlei) seem to be highly conserved which allows for the development of specific probe-based assays that may be used to detect all individuals within the species ([@bib0870; @bib0775; @bib0785; @bib0805]). Conversely, if it is assumed that some clades do represent single species with genotypic diverse members, they are so diverse that no single assay may be able to detect all genotypes and therefore all individuals within the species. This necessitates the development of multiple assays or probes for geographically diverse populations ([@bib0360; @bib0195; @bib0755]).

The same generalities are found for all clades in the literature, *i.e.* when different genotypes are observed from a single host species and genotypes group within a monophyletic clade, it is assumed that these are the same *Theileria* species. Conversely, finding a single genotype associated with a single host species, even if the sampling was small and the genotype has not previously been observed, will lead to the conclusion that this is a unique species. From an evolutionary perspective this situation is extremely confusing. It suggests recent speciation of genotypes such as *T. parva, T.* sp. (buffalo) and *T.* sp. (bougasvlei) that allows conservation of the 18S V4 hyper-variable region ([@bib0605; @bib0785]), even though evidence suggests a more ancient origin, since *T. parva* for example shows extensive genetic diversity in field populations ([@bib0630]). It also implies that the 18S ribosomal genes in the *T. buffeli, T. equi* and *T. mutans* clades had undergone rapid evolution, contravening the ribosomal molecular clock ([@bib0520]), or that these clades have an ancient origin with diversification of lineages, while maintaining their species identity. The latter may occur via bottleneck events that result in clonal populations in which the 18S gene diverged ([@bib0980; @bib0975; @bib0630]). Why this would be more prone in certain clades is uncertain, while divergence of the whole genome may be expected. Designation of species then becomes arbitrary and retaining diverse genotypes in a single species may be a social and philosophic response to a complex problem ([@bib0975]). An alternative and more parsimonious scenario would posit dispersal and geographic isolation linked with speciation of vertebrate host species during the Middle--Late Miocene (\~13--8 MYA) for the ancestral lineages to the Bubalina (African and Asiatic buffalo and cattle) ([@bib0375]) and the Pliocene (4--3 MYA) for the Bovina (cattle and bison) ([@bib0375; @bib0380]) and caballine and non-caballine equids ([@bib1010]). This coincided with diversification of *Theileria* parasites within the different clades ([@bib0240; @bib0330]). Subsequent breakdown of geographic barriers could have resulted in co-infection of Bovini hosts by related genotypes unable to sexually recombine, but still able to infect similar vectors and hosts. In this case, the genotypic diversity observed within the respective clades should be interpreted as distinct lineages, *i.e.* species. With \~6000 named apicomplexan species, which comprise only 0.1% of the estimated number of apicomplexan species (1.2--10 million) ([@bib0640]), it seems rather conservative that only 91 genotypes and \~40 species have been described thus far in the *Theileria*.

4. Sensitivity of molecular assays, carrier state and parasitaemia ranges {#s0045}
=========================================================================

The theoretical limit of detection (LOD) of molecular PCR assays is three molecules per assay, which generally equates with a sensitivity cut-off of \~37 cycles ([@bib0155]). In practice, however, this may range from 3 -- \> 100 molecules and a cut-off from 37 to 40 cycles ([@bib0140; @bib0105]). This depends on a complex array of factors, including assay mixture, robustness of the polymerase enzyme, inhibitors in the sample, primer and probe design and thermodynamics, effective temperature cycling and detector sensitivity of PCR equipment. In the case of *Theileria*, most assays detect genomic DNA and sensitivity will therefore also be influenced by DNA extraction efficiency (*i.e.* yield), gene copy number in the genome, number of parasites (genomic copies) per cell sampled and the parasitaemia level.

Sensitive quantitative real-time PCR assays have been developed for *T. parva* and *T. equi*. In all cases the analytical LOD ranges from 3 to 10 copies, with efficiencies that fall within the acceptable levels for a PCR assay ([@bib0495; @bib0895; @bib0105; @bib0775]). It is, however, of interest to put this into practical perspective with regard to the detection limit in carrier animals. For the *T. parva* test, the LOD for whole blood was \~10 parasites from the equivalent of 5 µL whole blood ([@bib0895]). This calculates back to \~2000 parasites/mL of blood and 19 million parasites in a 500 kg buffalo. Similarly, nested PCR based on the p104 gene, conventional PCR based on the p104 gene and reverse line blot for *T. parva* had LOD of 400--2000 parasites/mL of blood ([@bib0915; @bib0720; @bib0690]). For the *T. equi* assay, the LOD was 190 parasites from the equivalent of 5 µL whole blood ([@bib0105]). This calculates to a detection limit of 376--1520 million parasites in a 500 kg horse if the average number of parasites varies from 1 to 4 per red blood cell. Similarly, tests for *T. annulata* ([@bib0260; @bib0500; @bib0805]) and *T. buffeli* ([@bib0430]) gave LOD of 23--54 and 108 million parasites, respectively, in cattle weighing 500 kg. A sensitive PCR-RLB assay for *T. annulata*, based on the cytochrome b gene, gave a LOD of 100,000 parasites per liter ([@bib0115]). A nested PCR for *T. ovis* gave a LOD of 1200 parasites/mL of blood ([@bib0045]), which calculates to a detection limit of 5.7 million parasites in an 80 kg sheep. It would thus seem that in general, the LOD in animals is \>400,000 parasites/L blood, implying that assays for most *Theileria* parasites, even if sensitive from an analytical perspective, may fail to detect carrier animals from a diagnostic perspective. The potential for false-negative results can, however, only be assessed within the biological context of the parasite within its vertebrate host, *i.e.* parasitaemia ranges and the carrier-state that impacts on the ability to infect the tick vector and subsequent transmission to a new host.

Parasitaemia is generally expressed as percentage infected red blood cells. It would seem that all *Theileria* species have defined parasitaemia ranges ([@bib1060; @bib0985]). During clinical reactions, piroplasm parasitaemia may be as high as 1--45% depending on the species ([@bib1000; @bib1055; @bib0255; @bib0525; @bib0855]), but this generally drops well below 1% for the asymptomatic carrier state ([@bib1000; @bib1060; @bib0345; @bib1070; @bib0985]). Quantitative real-time PCR has allowed estimation of parasitaemia ranges in hosts and the first interesting observation was that parasitaemia ranges approximate normal distributions ([@bib0770; @bib0785]). These ranges will be determined by the specific biology of the parasite in the carrier state, *i.e.* ability to maintain and propagate in the vertebrate host (will be discussed later). It also implies that the specific parasitaemia range of a species may determine its practical LOD. As such, \>95% of the *T. parva* population in African buffalo have parasitaemias \>0.00001%, which is well above the determined detection limit ([@bib0770]). The same holds for *T.* sp. (buffalo) and *T.* sp. (bougasvlei) ([@bib0770; @bib0785]). It is difficult to make similar estimations for other *Theileria* species since the numbers of animals sampled do not allow construction of representative frequency distribution plots of published Ct values ([@bib0430; @bib0495; @bib0105]). However, from work performed in our own laboratories we may conclude that the parasitaemia range for *T. equi* is above the LOD in horses from endemic areas (personal observation). Similarly, most benign *Theileria* species generally have higher parasitaemia ranges in the carrier state and it may be concluded that real-time PCR assays for most *Theileria* species should be able to detect the majority of infected animals in a herd.

Exceptions to this may occur where the sensitivity of the assay is affected by the presence of mixed infections. Sensitivity of the RLB is severely affected by the fact that universal primers are used and these are depleted by the predominant species present, thereby suppressing the signal from less abundant template ([@bib0770]). The sensitivity of the hybridisation assay for *T. parva* ([@bib0895]) is similarly affected by the presence of *T.* sp. (buffalo)-like parasites, since the primers for this assay also amplify the latter parasite template ([@bib0770]). Design of more specific primers and stringent conditions alleviated this suppression problem, at the cost of being slightly less sensitive in regard to analytical sensitivity, but with increased overall performance for field samples ([@bib0775]). Other assays that may also be affected by sensitivity suppression include the cox III assay that uses universal primers and may be compounded by the implementation of a nested PCR strategy ([@bib0200]). In regard to the latter, nested PCR may increase overall sensitivity ([@bib0875; @bib0690; @bib0985]), but may introduce contamination problems in the routine diagnostic laboratory, or if primers are not specific, still lead to PCR suppression by the most dominant genotypes. In addition, it is well accepted that parasitaemia can fluctuate and drop below detection limits, only to increase during relapse, the so-called sporadic carrier state ([@bib0685]). This generally occurs under conditions of stress, immune suppression or splenectomy ([@bib0400; @bib1085]). Fluctuation in parasitaemia from below the PCR LOD is, however, not extensively documented and may contribute little to herd surveillance, but may have a significant impact on disease epidemiology, precipitating in disease outbreaks. Multiple testing rounds are generally considered as solution for this eventuality ([@bib0985]).

The carrier-state for piroplasmida may be defined as the long-term persistence of a parasite in its host, with the ability of transmission to other hosts via vector infection, to maintain a transmission cycle. Long-term persistence implies that the parasite can maintain itself and propagate in the vertebrate host while escaping the immune system. In most *Theileria*, it is accepted that the piroplasm stage is maintained in the host via asexual division and re-infection of red blood cells ([@bib0685]). In the case of *T. parva*, limited division of piroplasms has been observed ([@bib0220; @bib0280]). However, it has been proposed that a reservoir of schizonts that maintains parasitaemia levels exists that escapes the immune system, especially since schizonts sampled 657 days after initial infection could be propagated in cell culture ([@bib0345]). Maintenance of parasitaemia levels is necessary, since red blood cells have a lifespan that range from 70 to 160 days in large mammals before being destroyed ([@bib0015]). This would imply that parasites need to replicate and re-infect new red blood cells at least once in this period to maintain their parasitaemia levels. In this regard, remarkable stability in piroplasm parasitaemia levels has been observed in *T. parva* carrier buffalo kept under tick-free conditions where animals maintained parasitaemia levels for up to 20 years ([@bib0785]). It is therefore also accepted that once infected, animals may remain lifelong carriers of *Theileria* ([@bib0255; @bib0685]). While this is generally true, fluctuations in parasitaemia and loss of carrier state has also been documented, especially in cases where true carrier-status cannot be established, such as the case for Corridor disease and East Coast Fever.

In the case of East Coast Fever, infection of animals using specific strains of Muguga resulted in fluctuating parasitaemia above and below the LOD of the assay, showing in principle that fluctuating parasitaemia was possible for *T. parva*. Animals infected with this strain will eventually clear it completely and will not be infective to ticks ([@bib0120; @bib0915; @bib0690]). Whether this is representative for field strains is not known, since this strain has been propagated under laboratory conditions for extensive time periods. In contrast, the Marikebuni strain maintained the carrier-state indefinitely well above the LOD ([@bib0120; @bib0915]). Prevalence of *T. parva* in cattle from East Coast fever endemic regions range between 37 and 42% using nested PCR ([@bib0690]), compared to \~80% in buffalo ([@bib0770]), suggesting that the former is not compatible with an endemic stable situation. In East Coast fever, the carrier-state may therefore be strain dependent and intermittent. For Corridor disease, cattle infected with *T. parva* that survive may maintain the infection for up to 3 months, but with decreasing parasitaemia until the infection is cleared, with no relapse observed yet (even in splenectomised cattle) and unable to infect ticks ([@bib0625]). The latter case may represent the dynamics of a parasite not fully adapted to its host and where the carrier-state may only be intermittent. In this case, the seasonality of brown ear ticks in South Africa preclude the maintenance of a transmission cycle ([@bib0680; @bib0625]), and buffalo-adapted *T. parva* may therefore not have true carrier status in cattle. The latter becomes an important consideration in epidemiological surveillance, since the presence of parasite DNA or positive serology may not be indicative of true host carrier status, but only exposure to parasites during tick transmission.

5. Epidemiology in the context of species {#s0050}
=========================================

*Theileria* epidemiology considers parasite and vector distribution, mortality and morbidity of disease outbreaks, disease outbreak risk assessment and disease control measures, socio-economic factors, climate change, host resistance and susceptibility ([@bib0290]). While many of these factors may be addressed by clinical differential diagnosis, vector mapping, vaccination strategies and control policy, serological and molecular diagnosis remain central to confirmation of parasite identity, distribution, disease surveillance, assessment of vaccine and as tool for informative control policies ([@bib0080]). From a disease control standpoint, accurate diagnostics and communication is hampered by loose treatment of species concepts and lumping of genotypes into large groups collectively designated as single species. Examples of this are the emergence of different virulent "strains or genotypes" from "*T. buffeli*" that cause outbreaks in geographic diverse regions ([@bib0420; @bib0450; @bib0910]), or the presence of *T. parva* in South Africa that causes buffalo-derived Corridor disease, but not cattle-derived East Coast fever ([@bib0625]). In contrast to the *T. buffeli* clade where ample genetic evidence exists for diverse genotypes, the case for separating the *T. parva* sub-types based on genetic evidence is not clear and the trinomial system used to distinguish Corridor disease (*T. parva lawrencei*), East Coast fever (*T. parva parva*) and January disease (*T. parva bovis*) was abolished for more than 20 years ago ([@bib0685; @bib0760]). The biological differences between these "strains" are, however, well documented ([@bib0535; @bib0760]) and treatment as one species disregards the epidemiology of these parasites. The search for markers to distinguish between these strains has continued, but with little success ([@bib0900; @bib0905]). Again, the probability exists that these parasites are related via an evolutionary continuum, *i.e.* recent divergence that will eventually result in speciation due to host specificity.

The study of parasite epidemiology is further complicated by treatment of distinct genotypes as discrete units (species), since this may mask additive or competitive effects between genotypic populations. Treatment of *T.* sp. (buffalo) and *T.* sp. (bougasvlei) as one species ([@bib0190; @bib0610]) could have missed their skewed geographic distribution with regard to each other ([@bib0785]). Similarly, genotypes from the *T. mutans, T. velifera* and *T. buffeli* clades ([@bib0195; @bib0205]) have skewed distributions in cattle and African buffalo in southern Africa based on screening data of \~1000 cattle and 1000 buffalo distributed across the region (B.J. Mans, personal observation). While these are anectodal in regard to all *Theileria* genotypes, similar disparities in genotypic distributions are likely to be prevalent in different hosts and geographic regions. To ultimately understand the phylogeographic history of the *Theileria* genus, all genotypes need to be accounted for. In this regard, lumping genotypes into species does not unify, but rather obscures lineage specific life histories.

6. Conclusion {#s0055}
=============

Extensive resources exist for diagnostics of *Theileria* parasites. However, many of the available assays are restricted by limitations in specificity and sensitivity, and a positive diagnosis may in some cases only be made by multiple assays or xenodiagnosis. Critical examination of the measurements of uncertainty inherent in all assays will allow future improvements in diagnostic capability and may also contribute towards a better understanding of parasite biology. This in turn should have a positive impact on disease epidemiology.
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###### 

Phylogenetic analysis of *Theileria* genotypes. The 18S ribosomal RNA sequences were extracted from GenBank using text based queries and BLAST analysis. Final non-redundant dataset were obtained by phylogenetic analysis and manual curating. The dataset were trimmed to include the V4 hyper-variable region, aligned using MAFFT (auto, 200PAM/k = 2; [@bib0475]) and analysed using neighbour-joining (bootstrap = 1000, matrix = number of differences) with Mega5 ([@bib0935]). Host and geographic data for genotypes are indicated and were extracted from GenBank files or literature in the case of reverse line blot analysis.
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###### 

A summary of diagnostic assays that exist for the *Theileria*. Indicated are *Theileria* species, tick vectors, hosts, diseases caused, serological and diagnostic assays developed.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Theileria* spp.                           Tick vector                                            Hosts                                                                   Disease                                                                                Serology         Molecular
  ------------------------------------------ ------------------------------------------------------ ----------------------------------------------------------------------- -------------------------------------------------------------------------------------- ---------------- -------------------------------
  *T. parva*                                 *Rhipicephalus appendiculatus*; *R. zambeziensis*      Cattle, African buffalo                                                 Fatal; East Coast fever, Corridor disease, Zimbabwean theileriosis (January disease)   1, 2, 3          4, 5, 6, 7, 8

  *T. mutans*                                *Amblyomma sp.*                                        African buffalo, cattle                                                 Benign theileriosis                                                                    1, 9, 10         4, 8, 11

  *T. taurotragi*                            *Rhipicephalus sp.*                                    Cattle, eland (sheep)                                                   Benign African theileriosis                                                            9, 12            4, 8

  *T. velifera*                              *Amblyomma sp.*                                        African buffalo, cattle                                                 Benign                                                                                 None             4, 8

  *T. buffeli*/\                             *Haemaphysalis sp.*                                    African buffalo, cattle, Water buffalo                                  Oriental theileriosis                                                                  13, 14, 15, 16   4, 8, 17, 18, 19, 20
  *T. sergenti*\                                                                                                                                                                                                                                                                    
  *T. orientalis*\                                                                                                                                                                                                                                                                  
  *T. sinesis*                                                                                                                                                                                                                                                                      

  *T. lestoquardi*                           *Hyalomma sp.*                                         Sheep, goats                                                            Malignant sheep theileriosis                                                           21, 22           23, 24, 25

  *T. ovis*                                  *Hyalomma sp. Rhipicephalus*?                          Sheep, goats                                                            Benign                                                                                 None             23, 26, 27, 28, 29

  *T. separata*                              *Rhipicephalus sp.*, *Hyalomma sp.*                    Sheep, antelope                                                         Benign/pathogenic                                                                      None             23, 24

  *T. annulata*                              *Hyalomma sp.*                                         Cattle, water/domestic buffalo                                          Fata; Tropical or Mediterranean theileriosis                                           30, 31, 32, 33   4, 17, 24, 26, 34, 35, 36, 37

  *T.* sp.(buffalo); *T.* sp. (bougasvlei)   Not known                                              African buffalo (South Africa); African buffalo, cattle (East Africa)   Benign                                                                                 38               8, 39

  T. sp. (sable)                             *R. evertsi*/*R. appendiculatus*?                      Sable                                                                   Malignant                                                                              None             40

  *T. equi*                                  *Hyalomma spp., Rhipicephalus spp.*                    Horses, donkeys, giraffes                                               Acute to chronic                                                                       41, 42, 43, 44   45, 46, 47, 48

  *T. annae*                                 *Ixodes sp.*, *Rhipicephalus sp.*, *Dermacentor sp.*   Dogs, foxes                                                             Severe, regenerative anaemia                                                           None             49, 50

  *T. uilenbergi*                            *Haemaphysalis sp.*                                    Sheep, goats, sika, red deer                                            Cervine theileriosis                                                                   51               52, 53

  *T. luwenshuni*                            *Haemaphysalis sp.*                                    Sheep, goats, sika, red deer                                            Cervine theileriosis                                                                   51               26, 52, 54

  *T. bicornis*                              *R. evertsi evertsi*                                   Black, white and Indian rhinoceros                                      Benign                                                                                 None             55

  *T. capreoli*                              *Ixodes ricinus*                                       Sika, red deer                                                          Theileriosis?                                                                          None             55, 56

  *T. cervi*                                 *Amblyomma americanum*                                 White-tailed deer, elk                                                  Benign                                                                                 57               58

  *T.* sp. OT 3                              *Haemaphysalis sp.*?                                   ?                                                                       Theileriosis?                                                                          None             26, 54, 59

  *T.* sp. MK                                Not known                                              Goats, sheep                                                            Benign                                                                                 None             60
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1\. Complement-fixation assay ([@bib0860]). 2. Piroplasm and schizont IFAT and ELISA ([@bib0145; @bib0150; @bib0340]). 3. PIM indirect ELISA ([@bib0465]). 4. RLB ([@bib0350]). 5. Conventional and nested PCR for p67, p104, Tpr ([@bib0120; @bib0915; @bib0690; @bib0770]). 6. Real-time PCR targeting 18S ([@bib0895; @bib0745; @bib0780]). 7. LAMP targeting PIM and p150 ([@bib0955]). 8. Pan-FRET real-time PCR for Cox III ([@bib0195]). 9. Piroplasm IFAT ([@bib0250]). 10. Indirect ELISA for p32 ([@bib0470]). 11. Conventional PCR based on non-coding region ([@bib0135]). 12. Piroplasm IFAT ([@bib0440]). 13. Piroplasm IFAT ([@bib1005; @bib0735]), 14. Piroplasm extract ELISA ([@bib0890]). 15. Latex agglutination test for major piroplasm surface protein p33 ([@bib0435]). 16. Indirect ELISA for p33 ([@bib1020]). 17. Conventional PCR for β-tubulin, MPSP, p23, p32, p33, p34 ([@bib0940; @bib0485; @bib0515; @bib0335; @bib0845; @bib0165; @bib0570; @bib0585; @bib0710]). 18. Semi-nested PCR for 18S rRNA ([@bib0310]). 19. Multiplex-tandem real-time PCR for the major piroplasm surface protein, 23-kDa piroplasm membrane protein and ITS1 ([@bib0755]). 20. LAMP for p33 and ITS ([@bib1015; @bib0580]). 21. Schizont IFAT ([@bib0550]). 22. Clone 5 ELISA ([@bib0075]). 23. RLB ([@bib0875]). 24. PCR-RFLP of 18S rRNA ([@bib0390]). 25. LAMP of clone 5 ([@bib0820]). 26. Suspension arrays ([@bib0800]). 27. Nested PCR of 18S rRNA ([@bib0045]). 28. PCR-RFLP of 18S RNA ([@bib0390]). 29. 5.8S RNA PCR ([@bib1080]). 30. Piroplasm and schizont IFAT and ELISA ([@bib0340; @bib0445; @bib0265]). 31. TaSP, Tams1 indirect ELISAs ([@bib0070; @bib0825; @bib0790]). 32. Competitive ELISA for TaSP ([@bib0795]). 33. TaSP lateral flow device ([@bib0010]). 34. Cytochrome b RLB ([@bib0115]). 35. Conventional PCR for cytochrome b, HSP70 and *Tams1* ([@bib0260; @bib0885; @bib0500; @bib0230]). 36. Conventional and real-time PCR for 18S rRNA gene ([@bib0415; @bib0805]). 37. LAMP for the 18S rRNA, ITS and TA04795 ([@bib0815; @bib0575]). 38. Schizont IFAT ([@bib0225]). 39. Real-time LNA probe assay ([@bib0785]). 40. Real-time PCR (Pienaar, Personal communication). 41. Piroplasm IFAT and complement fixation test ([@bib0695]). 42. Competitive ELISA of EMA-1 ([@bib0505]). 43. Indirect ELISA for EMA-2 ([@bib0405]). 44. Immuno-chromatographic test for EMA-2 ([@bib0410]). 45. RLB ([@bib0160]). 46. Conventional PCR of EMA-1, β-tubulin, 18S rRNA ([@bib0165; @bib0025; @bib0395; @bib0840]). 47. Real-time PCR and high resolution melt analysis of 18S rRNA ([@bib0495; @bib0105; @bib0835]). 48. LAMP of EMA-1 and 18S rRNA ([@bib0030; @bib0035; @bib1025]). 49. RLB ([@bib1045]). 50. Conventional PCR-RFLP of 18S rRNA ([@bib0425]). 51. TlHSP70, rTulP ELISA ([@bib0635; @bib0600]). 52. RLB ([@bib0675]). 53. Conventional PCR of 18S rRNA, RPS8 ([@bib1040; @bib0965; @bib1080]). 54. RLB ([@bib0650]). 55. RLB ([@bib0665]). 55. RLB ([@bib0295]). 56. Conventional PCR of 18S rRNA ([@bib0560]). 57. IFAT ([@bib0850]). 58. PCR and sequencing of 18S rRNA ([@bib0180]). 59. Conventional PCR of 18S rRNA ([@bib0970]). 60. RLB and conventional PCR of 18S rRNA ([@bib0050; @bib0055]).
